DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Kantarjian H, Oki Y, Garcia-Manero G. et al.
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia.
Blood 2007; 109: 52-57
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.